Biblio Discovery — Demo Discovery Service

5 hasil untuk "David Sullivan"

Menampilkan 1–5 · 0,20 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant

    Emi Takashita; Noriko Kinoshita; Seiya Yamayoshi dkk.

    New England Journal of Medicine · 2022 · Inggris · OpenAlex Scopus

    e Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron VariantTo the Editor: In November 2021, the B.1.1.529(omicron) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was detected in South Africa. 1 Since then, omicron has rapidly spread around the world.On…

  2. Artikel Jurnal Teks lengkap

    SARS-CoV-2–specific CD8+ T cell responses in convalescent COVID-19 individuals

    Hassen Kared; Andrew D. Redd; Evan M. Bloch dkk.

    Journal of Clinical Investigation · 2021 · Inggris · OpenAlex Scopus

    Characterization of the T cell response in individuals who recover from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is critical to understanding its contribution to protective immunity. A multiplexed peptide-MHC tetramer approach was used to screen 408 SARS-CoV-2…

  3. Artikel Jurnal Teks lengkap

    Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population

    Sabra L. Klein; Andrew S Pekosz; Han-Sol Park dkk.

    Journal of Clinical Investigation · 2020 · Inggris · OpenAlex Scopus

    Convalescent plasma is a leading treatment for coronavirus disease 2019 (COVID-19), but there is a paucity of data identifying its therapeutic efficacy. Among 126 potential convalescent plasma donors, the humoral immune response was evaluated using a severe acute respiratory syndrome coronavirus 2…

  4. Artikel Jurnal Teks lengkap

    Deployment of convalescent plasma for the prevention and treatment of COVID-19

    Evan M. Bloch; Shmuel Shoham; Arturo Casadevall dkk.

    Journal of Clinical Investigation · 2020 · Inggris · OpenAlex Scopus

    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), has spurred a global health crisis. To date, there are no proven options for prophylaxis for those who have been exposed to SARS-CoV-2, nor therapy for those who develop COVID-19. Immune…

  5. Artikel Jurnal Teks lengkap

    Early Outpatient Treatment for Covid-19 with Convalescent Plasma

    David Sullivan; Kelly A. Gebo; Shmuel Shoham dkk.

    New England Journal of Medicine · 2022 · Inggris · OpenAlex Scopus

    BACKGROUND: Polyclonal convalescent plasma may be obtained from donors who have recovered from coronavirus disease 2019 (Covid-19). The efficacy of this plasma in preventing serious complications in outpatients with recent-onset Covid-19 is uncertain. METHODS: In this multicenter, double-blind…